Biopharmaceutical studies on aminoethanesulfonylpiperidine and related compounds. I. Absorption, excretion, metabolism, and some pharmacological activities.
D000700:Analgesics / Q000378:metabolism; D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D001646:Bile / Q000032:analysis / Q000378:metabolism; D001702:Biopharmaceutics; D001923:Brain Chemistry; D002490:Central Nervous System / Q000187:drug effects; D002855:Chromatography, Thin Layer; D006634:Histamine H1 Antagonists / Q000378:metabolism; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D008297:Male; D009206:Myocardium / Q000032:analysis; D010880:Piperidines / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D011485:Protein Binding; D051381:Rats; D013154:Spleen / Q000032:analysis; D013654:Taurine / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine
D000700:Analgesics; D006634:Histamine H1 Antagonists; D010880:Piperidines; D013654:Taurine